No.,Title,Link
1,Early differentiating between the chemotherapy responders and nonresponders: preliminary results with ultrasonic spectrum analysis of the RF time series in preclinical breast cancer models,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0248-y
2,Radiomics models for diagnosing microvascular invasion in hepatocellular carcinoma: which model is the best model?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0249-x
3,Diffusion-weighted magnetic resonance imaging in bladder cancer: comparison of readout-segmented and single-shot EPI techniques,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0245-1
4,18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0246-0
5,How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncology,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0241-5
6,Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0243-3
7,Retraction Note to: Ultrasound Elastography supplement assessing nodal status of magnetic resonance imaging staged cervical N0 patients with nasopharyngeal carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0242-4
8,Clinical impact of variability on CT radiomics and suggestions for suitable feature selection: a focus on lung cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0239-z
9,Imaging and clinical features of Castleman Disease,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0238-0
10,PET/MRI and PET/CT hybrid imaging of rectal cancer – description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0237-1
11,Accuracy and complications of CT-guided pulmonary core biopsy in small nodules: a single-center experience,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0240-6
12,Diagnostic value of spectral reconstructions in detecting incidental skeletal muscle metastases in CT staging examinations,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0235-3
13,Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0234-4
14,Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0233-5
15,Comparing clinicopathological features and prognosis of primary pulmonary invasive mucinous adenocarcinoma based on computed tomography findings,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0236-2
16,Does establishing a preoperative nomogram including ultrasonographic findings help predict the likelihood of malignancy in patients with microcalcifications?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0229-1
17,Multi-window CT based Radiomic signatures in differentiating indolent versus aggressive lung cancers in the National Lung Screening Trial: a retrospective study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0232-6
18,Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0231-7
19,Enhancing prognosis prediction using pre-treatment nodal SUVmax and HPV status in cervical squamous cell carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0226-4
20,Value of CT-guided percutaneous needle biopsy of bone in the diagnosis of lymphomas based on PET/CT results,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0230-8
21,Deep learning networks find unique mammographic differences in previous negative mammograms between interval and screen-detected cancers: a case-case study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0227-3
22,Improved detection of metastatic lymph nodes in oesophageal squamous cell carcinoma by combined interpretation of fluorine-18-fluorodeoxyglucose positron-emission tomography/computed tomography,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0225-5
23,Non-mono-exponential diffusion models for assessing early response of liver metastases to chemotherapy in colorectal Cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0228-2
24,Comparative effect of iso-osmolar versus low-osmolar contrast media on the incidence of contrast-induced acute kidney injury in diabetic patients: a systematic review and meta-analysis,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0224-6
25,68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0220-x
26,Predicting malignant potential of subsolid nodules: can radiomics preempt longitudinal follow up CT?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0223-7
27,Use of quantitative T2 mapping for the assessment of renal cell carcinomas: first results,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0222-8
28,CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0221-9
29,Postoperative recurrence of clinical early-stage non-small cell lung cancers: a comparison between solid and subsolid nodules,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0219-3
30,Primary hepatic perivascular epithelioid cell tumors: imaging findings with histopathological correlation,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0212-x
31,Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0218-4
32,Comparison of diffusion kurtosis imaging versus diffusion weighted imaging in predicting the recurrence of early stage single nodules of hepatocellular carcinoma treated by radiofrequency ablation,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0213-9
33,Prediction of hepatocellular carcinoma response to 90Yttrium radioembolization using volumetric ADC histogram quantification: preliminary results,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0216-6
34,The role of 18F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0217-5
35,Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0215-7
36,Optimizing prostate cancer accumulating model: combined PI-RADS v2 with prostate specific antigen and its derivative data,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0208-6
37,Quantitative computed tomography texture analysis: can it improve diagnostic accuracy to differentiate malignant lymph nodes?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0214-8
38,Diagnostic value of multislice spiral computed tomography (CT) combined with CT angiography for intra-abdominal undescended testis secondary seminomas,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0210-z
39,Intra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistribution,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0211-y
40,Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0209-5
41,Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0207-7
42,Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0206-8
43,Application of a machine learning method to whole brain white matter injury after radiotherapy for nasopharyngeal carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0203-y
44,Metabolic tumor burden on postsurgical PET/CT predicts survival of patients with gastric cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0205-9
45,Choroid plexus tumours on MRI: similarities and distinctions in different grades,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0200-1
46,Ultrasound-guided percutaneous laser ablation for papillary thyroid microcarcinoma: a retrospective analysis of 37 patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0204-x
47,Evaluation of percutaneous unilateral trans-femoral implantation of side-hole port-catheter system with coil only fixed-catheter-tip for hepatic arterial infusion chemotherapy,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0202-z
48,Probabilistic independent component analysis of dynamic susceptibility contrast perfusion MRI in metastatic brain tumors,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0201-0
49,Asymptomatic versus symptomatic solid pseudopapillary tumors of the pancreas: clinical and MDCT manifestations,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0198-4
50,RETRACTED ARTICLE: Ultrasound Elastography supplement assessing nodal status of magnetic resonance imaging staged cervical N0 patients with nasopharyngeal carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0199-3
51,Early differentiating between the chemotherapy responders and nonresponders: preliminary results with ultrasonic spectrum analysis of the RF time series in preclinical breast cancer models,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0248-y
52,Radiomics models for diagnosing microvascular invasion in hepatocellular carcinoma: which model is the best model?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0249-x
53,Diffusion-weighted magnetic resonance imaging in bladder cancer: comparison of readout-segmented and single-shot EPI techniques,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0245-1
54,18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0246-0
55,How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncology,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0241-5
56,Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0243-3
57,Retraction Note to: Ultrasound Elastography supplement assessing nodal status of magnetic resonance imaging staged cervical N0 patients with nasopharyngeal carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0242-4
58,Clinical impact of variability on CT radiomics and suggestions for suitable feature selection: a focus on lung cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0239-z
59,Imaging and clinical features of Castleman Disease,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0238-0
60,PET/MRI and PET/CT hybrid imaging of rectal cancer – description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0237-1
61,Accuracy and complications of CT-guided pulmonary core biopsy in small nodules: a single-center experience,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0240-6
62,Diagnostic value of spectral reconstructions in detecting incidental skeletal muscle metastases in CT staging examinations,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0235-3
63,Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0234-4
64,Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0233-5
65,Comparing clinicopathological features and prognosis of primary pulmonary invasive mucinous adenocarcinoma based on computed tomography findings,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0236-2
66,Does establishing a preoperative nomogram including ultrasonographic findings help predict the likelihood of malignancy in patients with microcalcifications?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0229-1
67,Multi-window CT based Radiomic signatures in differentiating indolent versus aggressive lung cancers in the National Lung Screening Trial: a retrospective study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0232-6
68,Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0231-7
69,Enhancing prognosis prediction using pre-treatment nodal SUVmax and HPV status in cervical squamous cell carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0226-4
70,Value of CT-guided percutaneous needle biopsy of bone in the diagnosis of lymphomas based on PET/CT results,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0230-8
71,Deep learning networks find unique mammographic differences in previous negative mammograms between interval and screen-detected cancers: a case-case study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0227-3
72,Improved detection of metastatic lymph nodes in oesophageal squamous cell carcinoma by combined interpretation of fluorine-18-fluorodeoxyglucose positron-emission tomography/computed tomography,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0225-5
73,Non-mono-exponential diffusion models for assessing early response of liver metastases to chemotherapy in colorectal Cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0228-2
74,Comparative effect of iso-osmolar versus low-osmolar contrast media on the incidence of contrast-induced acute kidney injury in diabetic patients: a systematic review and meta-analysis,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0224-6
75,68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0220-x
76,Predicting malignant potential of subsolid nodules: can radiomics preempt longitudinal follow up CT?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0223-7
77,Use of quantitative T2 mapping for the assessment of renal cell carcinomas: first results,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0222-8
78,CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0221-9
79,Postoperative recurrence of clinical early-stage non-small cell lung cancers: a comparison between solid and subsolid nodules,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0219-3
80,Primary hepatic perivascular epithelioid cell tumors: imaging findings with histopathological correlation,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0212-x
81,Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0218-4
82,Comparison of diffusion kurtosis imaging versus diffusion weighted imaging in predicting the recurrence of early stage single nodules of hepatocellular carcinoma treated by radiofrequency ablation,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0213-9
83,Prediction of hepatocellular carcinoma response to 90Yttrium radioembolization using volumetric ADC histogram quantification: preliminary results,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0216-6
84,The role of 18F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0217-5
85,Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0215-7
86,Optimizing prostate cancer accumulating model: combined PI-RADS v2 with prostate specific antigen and its derivative data,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0208-6
87,Quantitative computed tomography texture analysis: can it improve diagnostic accuracy to differentiate malignant lymph nodes?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0214-8
88,Diagnostic value of multislice spiral computed tomography (CT) combined with CT angiography for intra-abdominal undescended testis secondary seminomas,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0210-z
89,Intra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistribution,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0211-y
90,Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0209-5
91,Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0207-7
92,Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0206-8
93,Application of a machine learning method to whole brain white matter injury after radiotherapy for nasopharyngeal carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0203-y
94,Metabolic tumor burden on postsurgical PET/CT predicts survival of patients with gastric cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0205-9
95,Choroid plexus tumours on MRI: similarities and distinctions in different grades,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0200-1
96,Ultrasound-guided percutaneous laser ablation for papillary thyroid microcarcinoma: a retrospective analysis of 37 patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0204-x
97,Evaluation of percutaneous unilateral trans-femoral implantation of side-hole port-catheter system with coil only fixed-catheter-tip for hepatic arterial infusion chemotherapy,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0202-z
98,Probabilistic independent component analysis of dynamic susceptibility contrast perfusion MRI in metastatic brain tumors,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0201-0
99,Asymptomatic versus symptomatic solid pseudopapillary tumors of the pancreas: clinical and MDCT manifestations,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0198-4
100,RETRACTED ARTICLE: Ultrasound Elastography supplement assessing nodal status of magnetic resonance imaging staged cervical N0 patients with nasopharyngeal carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0199-3
101,CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0197-5
102,Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a comparative study of pharmacokinetic models and correlation with mRECIST criteria,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0189-5
103,Comparative analysis of the value of diffusion kurtosis imaging and diffusion-weighted imaging in evaluating the histological features of endometrial cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0196-6
104,Application of magnetic resonance diffusion kurtosis imaging for distinguishing histopathologic subtypes and grades of rectal carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0192-x
105,2020 vision or myopia? A personal perspective on the future of cancer imaging and an introduction to the sequels to the “How I Read Series”,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0194-8
106,CT texture analysis: a potential tool for predicting the Fuhrman grade of clear-cell renal carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0195-7
107,The utility of MRI histogram and texture analysis for the prediction of histological diagnosis in head and neck malignancies,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0193-9
108,Prediction of high nodal burden with ultrasound and magnetic resonance imaging in clinically node-negative breast cancer patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0191-y
109,Computed tomographic features of adenoid cystic carcinoma in the palate,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0190-z
110,Distribution of metastasis in the brain in relation to the hippocampus: a retrospective single-center analysis of 565 metastases in 116 patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-019-0188-6
111,Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0187-z
112,“Sentinel lymph node imaging with sequential SPECT/CT lymphoscintigraphy before and after neoadjuvant chemoradiotherapy in patients with cancer of the oesophagus or gastro-oesophageal junction – a pilot study”,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0185-1
113,CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0184-2
114,IDEAL-IQ in an oncologic population: meeting the challenge of concomitant liver fat and liver iron,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0167-3
115,Discrepancies of assessments in a RECIST 1.1 phase II clinical trial – association between adjudication rate and variability in images and tumors selection,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0186-0
116,Preoperative prediction of peripancreatic vein invasion by pancreatic head cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0179-z
117,Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017),http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0183-3
118,"The eye of the beholder: orbital metastases from midgut neuroendocrine tumors, a two institution experience",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0181-5
119,Tumor heterogeneity in gastrointestinal stromal tumors of the small bowel: volumetric CT texture analysis as a potential biomarker for risk stratification,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0182-4
120,Endometrial cancer: an overview of novelties in treatment and related imaging keypoints for local staging,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0180-6
121,"Mono, bi- and tri-exponential diffusion MRI modelling for renal solid masses and comparison with histopathological findings",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0178-0
122,Diffusion-weighted imaging of rectal cancer on repeatability and cancer characterization: an effect of b-value distribution study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0177-1
123,Detection of gastric cancer and its histological type based on iodine concentration in spectral CT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0176-2
124,Evaluation of pancreatic tumor development in KPC mice using multi-parametric MRI,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0172-6
125,Pain control for patients with hepatocellular carcinoma undergoing CT-guided percutaneous microwave ablation,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0174-4
126,"68Ga-PSMA PET/CT in prostate cancer patients – patterns of disease, benign findings and pitfalls",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0175-3
127,Diffusion-weighted MR imaging of locally advanced breast carcinoma: the optimal time window of predicting the early response to neoadjuvant chemotherapy,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0173-5
128,The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0170-8
129,Imaging and clinical features of primary hepatic sarcomatous carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0171-7
130,Accurate FDG PET tumor segmentation using the peritumoral halo layer method: a study in patients with esophageal squamous cell carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0169-1
131,Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0168-2
132,Findings of DTI-p maps in comparison with T2/T2-FLAIR to assess postoperative hyper-signal abnormal regions in patients with glioblastoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0166-4
133,Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0165-5
134,Retraction Note: Pre-treatment DWI as a predictor of overall survival in locally advanced pancreatic cancer treated with Cyberknife radiotherapy and sequential S-1 therapy,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0164-6
135,Proceedings of the International Cancer Imaging Society (ICIS) 18th Annual Teaching Course,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0160-x
136,Risk of renal events following intravenous iodinated contrast material administration among inpatients admitted with cancer a retrospective hospital claims analysis,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0159-3
137,Castleman disease versus lymphoma in neck lymph nodes: a comparative study using contrast-enhanced CT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0163-7
138,Whole-body magnetic resonance imaging of Li-Fraumeni syndrome patients: observations from a two rounds screening of Brazilian patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0162-8
139,Gastric heterotopic pancreas and stromal tumors smaller than 3 cm in diameter: clinical and computed tomography findings,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0161-9
140,11C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial),http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0158-4
141,Clinical efficacy of chemoembolization with simultaneous radiofrequency ablation for treatment of adrenal metastases from hepatocellular carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0157-5
142,The utility of measuring the apparent diffusion coefficient for peritumoral zone in assessing infiltration depth of endometrial cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0156-6
143,CT during celiac artery angiography for localization of clinically suspected small insulinomas,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0155-7
144,Fat-suppressed gadolinium-enhanced isotropic high-resolution 3D-GRE-T1WI for predicting small node metastases in patients with rectal cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0153-9
145,"
68
Ga-PSMA-PET/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0154-8
146,The role of initial 18F-FDG PET/CT in the management of patients with suspected extramedullary plasmocytoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0152-x
147,Solid component proportion is an important predictor of tumor invasiveness in clinical stage T1N0M0 (cT1N0M0) lung adenocarcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0147-7
148,Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0150-z
149,Image quality of arterial phase and parenchymal blood volume (PBV) maps derived from C-arm computed tomography in the evaluation of transarterial chemoembolization,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0151-y
150,An international survey on hybrid imaging: do technology advances preempt our training and education efforts?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0148-6
151,LI-RADS v2017 for liver nodules: how we read and report,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0149-5
152,Review of targeted therapy in chronic lymphocytic leukemia: what a radiologist needs to know about CT interpretation,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0146-8
153,Most-enhancing tumor volume by MRI radiomics predicts recurrence-free survival “early on” in neoadjuvant treatment of breast cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0145-9
154,Ultrasound shear wave elastography of breast lesions: correlation of anisotropy with clinical and histopathological findings,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0144-x
155,Added value of diffusion-weighted imaging in hepatic tumors and its impact on patient management,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0140-1
156,Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0143-y
157,MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0142-z
158,Primary carcinosarcoma of the liver: imaging features and clinical findings in six cases and a review of the literature,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0141-0
159,RETRACTED ARTICLE: Pre-treatment DWI as a predictor of overall survival in locally advanced pancreatic cancer treated with Cyberknife radiotherapy and sequential S-1 therapy,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0139-7
160,Cement pulmonary embolism as a complication of percutaneous vertebroplasty in cancer patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0138-8
161,Diagnostic performance of 18F-FDG PET/CT using point spread function reconstruction on initial staging of rectal cancer: a comparison study with conventional PET/CT and pelvic MRI,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0137-9
162,Changes in biodistribution on 68Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0136-x
163,18F–FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-018-0135-y
164,Identification of the pericardiacophrenic vein on CT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0134-4
165,68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0133-5
166,Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET/CT in prostate cancer patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0132-6
167,3.0T MRI for long-term observation of lung nodules post cryoablation: a pilot study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0131-7
168,"How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0130-8
169,Comparison of efficacy and complications of endoscopic and percutaneous biliary drainage in malignant obstructive jaundice: a systematic review and meta-analysis,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0129-1
170,Lymphomatosis cerebri: a rare variant of primary central nervous system lymphoma and MR imaging features,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0128-2
171,Portal vein embolization with n-butyl-cyanoacrylate through an ipsilateral approach before major hepatectomy: single center analysis of 50 consecutive patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0127-3
172,Proceedings of the International Cancer Imaging Society (ICIS) 17th Annual Teaching Course,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0126-4
173,18F-FDG PET/CT response in a phase 1/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0125-5
174,Osteoradionecrosis of the hyoid bone after intra-arterial chemoradiotherapy for oropharyngeal cancer: MR imaging findings,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0123-7
175,Subclinical focal cholangitis mimicking liver metastasis in asymptomatic patients with history of pancreatic ductal adenocarcinoma and biliary tree intervention,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0124-6
176,Primary hepatic neuroendocrine tumors: multi-modal imaging features with pathological correlations,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0120-x
177,Imaging characteristics of cardiac metastases in patients with malignant melanoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0122-8
178,Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0121-9
179,CT findings in patients with Cabazitaxel induced pelvic pain and haematuria: a case series,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0119-3
180,Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0118-4
181,Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0117-5
182,Review of radiological classifications of pancreatic cancer with peripancreatic vessel invasion: are new grading criteria required?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0115-7
183,Effect of region of interest size on ADC measurements in pancreatic adenocarcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0116-6
184,Intravoxel incoherent motion DWI of the pancreatic adenocarcinomas: monoexponential and biexponential apparent diffusion parameters and histopathological correlations,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0114-8
185,Reproducibility and repeatability of same-day two sequential FDG PET/MR and PET/CT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0113-9
186,Evaluation of metabolic response with 18F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0112-x
187,Imaging of hepatocellular carcinoma and image guided therapies - how we do it,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0110-z
188,The prognostic value of location and size change of pathological lymph nodes evaluated on CT-scan following radiotherapy in head and neck cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0111-y
189,Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0109-5
190,Whole-body MRI in pediatric patients with cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0107-7
191,DEB TACE for Intermediate and advanced HCC – Initial Experience in a Brazilian Cancer Center,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0108-6
192,CT texture analysis: a potential tool for prediction of survival in patients with metastatic clear cell carcinoma treated with sunitinib,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-017-0106-8
193,Assessment and diagnostic accuracy of lymph node status to predict stage III colon cancer using computed tomography,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0104-2
194,Radioiodine sinus uptake related to mucosal thickening or aspergilloma: a case series of an unrecognized event well evidenced by SPECT/CT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0105-1
195,3D analysis of apparent diffusion coefficient histograms in hepatocellular carcinoma: correlation with histological grade,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0103-3
196,Clinical and radiological features driving patient selection for antiangiogenic therapy in non-small cell lung cancer (NSCLC),http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0102-4
197,CT-perfusion measurements in pancreatic carcinoma with different kinetic models: Is there a chance for tumour grading based on functional parameters?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0100-6
198,Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0099-8
199,How we read FCH-PET/CT for prostate cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0101-5
200,Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0098-9
201,Utility of SUVmax on 18 F-FDG PET in detecting cervical nodal metastases,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0095-z
202,Impact of 3T multiparametric MRI and FDG-PET-CT in the evaluation of occult primary cancer with cervical node metastasis,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0097-x
203,Impact of combined FDG-PET/CT and MRI on the detection of local recurrence and nodal metastases in thyroid cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0096-y
204,"Erratum to: A method to assess image quality for Low-dose PET: analysis of SNR, CNR, bias and image noise",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0094-0
205,How We Read Oncologic FDG PET/CT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0091-3
206,"Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: 18F-FAU, 18F-FMAU, and 18F-FLT",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0092-2
207,Single-source chest-abdomen-pelvis cancer staging on a third generation dual-source CT system: comparison of automated tube potential selection to second generation dual-source CT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0093-1
208,Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0090-4
209,Comparison of computed tomography features between follicular neoplasm and nodular hyperplasia,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0089-x
210,Proceedings of the International Cancer Imaging Society (ICIS) 16th Annual Teaching Course,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0079-z
211,C-arm computed tomography and volume perfusion computed tomography (VPCT)-based assessment of blood volume changes in hepatocellular carcinoma in prediction of midterm tumor response to transarterial chemoembolization: a single center retrospective trial,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0088-y
212,A study on the value of computer-assisted assessment for SPECT/CT-scans in sentinel lymph node diagnostics of penile cancer as well as clinical reliability and morbidity of this procedure,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0087-z
213,Detection of a second malignancy in prostate cancer patients by using [18F]Choline PET/CT: a case series,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0085-1
214,"A method to assess image quality for Low-dose PET: analysis of SNR, CNR, bias and image noise",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0086-0
215,Diagnostic value of 3.0T 1H MRS with choline-containing compounds ratio (∆CCC) in primary malignant hepatic tumors,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0082-4
216,Gallium-68 perfusion positron emission tomography/computed tomography to assess pulmonary function in lung cancer patients undergoing surgery,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0081-5
217,Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0080-6
218,"68Ga-DOTATATE and 18F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0084-2
219,MRI of paediatric liver tumours: How we review and report,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0083-3
220,Cross-sectional imaging in cancers of the head and neck: how we review and report,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0075-3
221,CT in ovarian cancer staging: how to review and report with emphasis on abdominal and pelvic disease for surgical planning,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0076-2
222,Evaluation of locoregional invasiveness of small-sized non-small cell lung cancers by enhanced dual-energy computed tomography,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0077-1
223,How I report breast magnetic resonance imaging studies for breast cancer staging and screening,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0078-0
224,Dynamic contrast enhanced CT in nodule characterization: How we review and report,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0074-4
225,Advanced abdominal imaging with dual energy CT is feasible without increasing radiation dose,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0073-5
226,68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0072-6
227,Translational research in diagnosis and management of soft tissue tumours,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0071-7
228,Comparison of qualitative and semiquantitative strain elastography in breast lesions for diagnostic accuracy,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0070-8
229,MRI of endometrium cancer – how we do it,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0069-1
230,How to use CT texture analysis for prognostication of non-small cell lung cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0065-5
231,Prostate MRI based on PI-RADS version 2: how we review and report,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0068-2
232,How I read cancer imaging studies: the master class series,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0067-3
233,Chest CT for suspected pulmonary complications of oncologic therapies: how I review and report,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0066-4
234,Evaluation of fluorescence imaging with indocyanine green in hepatocellular carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0064-6
235,Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0063-7
236,Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and 18F-FDG PET/CT in patients on waiting-list for liver transplantation,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0062-8
237,Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0061-9
238,Cancer Imaging reviewer acknowledgement 2015,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0060-x
239,Intravoxel incoherent motion MRI as a biomarker of sorafenib treatment for advanced hepatocellular carcinoma: a pilot study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-016-0059-3
240,C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0057-x
241,Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0058-9
242,Image findings of cranial nerve pathology on [18F]-2- deoxy-D-glucose (FDG) positron emission tomography with computerized tomography (PET/CT): a pictorial essay,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0054-0
243,Prognostic significance of 18FDG PET/CT in colorectal cancer patients with liver metastases: a meta-analysis,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0055-z
244,Evidence-based medicine and clinical fluorodeoxyglucose PET/MRI in oncology,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0053-1
245,Changes of lung tumour volume on CT - prediction of the reliability of assessments,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0052-2
246,"Role of high resolution MR in assessment of cervical uterine carcinoma: staging, treatment planning and correlation with histopathology findings",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P43
247,The value of 68Ga-PSMA enhanced PET-CT and MR-PET in patients with biochemical recurrent prostate cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P39
248,Chemo cured the cancer: what about the patient?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O35
249,Role of molecular functional imaging in present era of evidence based cancer medicine: to image or to imagine?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P10
250,"Oxygen-enhanced MRI can accurately identify, quantify and map tumour hypoxia in preclinical models",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P9
251,The value of the FDG-GaTate and proliferation marker (ki-67) in the assessment of neuroendocrine tumours (NETs),http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P53
252,Dual-energy CT in oncology: technical principles and clinical prospects,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P51
253,Whole-body diffusion-weighted MRI for staging of women with cancer during pregnancy: a pilot study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P50
254,"Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P49
255,MR and PET/CT imaging in diagnosis of large pelvic masses,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P48
256,Value of DWI volumetry for assessment of complete rectal cancer response after CRT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P47
257,Do we need to wait? Does reducing time to prostate MRI postbiopsy interfere with staging?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P46
258,Female pelvic malignancy: spectrum encountered in district hospital: an aid to a general radiologist,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P45
259,MRI rectal cancer in Australia and New Zealand: an audit from the PETACC-6 trial,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P44
260,FDG-PET/CT pitfalls in gynecological and genitourinary oncological imaging,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P42
261,Brain lesions in oncology patients: recognising metastatic versus non metastatic lesions,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O40
262,"Tumour characterisation, staging and operability assessment in ovarian carcinoma: whole body diffusion-weighted MRI versus CT",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P40
263,Patient selection and treatment response assessment in radium-223 therapy,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P38
264,Paediatric renal tumors,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O37
265,Pediatric bone and soft-tissue sarcomas,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O36
266,"MRI in intracavitary brachytherapy planning for cervical cancer malignancy, the pitfalls and complications",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P36
267,Imaging techniques to diagnose radiation damage,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O34
268,Detection of gynaecological cancer in pregnancy,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P34
269,Reporting oncoimaging in the appropriate oncology setting,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P32
270,Percutaneous treatment of liver metastases,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O30
271,Structured reporting of metastatic disease for improving communication in comprehensive cancer centers- a feasibility study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P30
272,Hepatic lesions,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O28
273,Are contouring time and multimodality imaging prognostic factors for radiation therapy of advanced head and neck cancer?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P28
274,MRI assessment of treatment response,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O26
275,Thoracic pseudotumours: a pictorial essay,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P26
276,Imaging spectrum of lung adenocarcinoma with histopathological correlation,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P24
277,Benign lesions that mimic cancer: Ovarian,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O22
278,CT characteristic of early local recurrence after resection of the squamous cell carcinoma: comparison with CT characteristics of granulation tissue at stump site,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P22
279,Lung cancer staging,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O20
280,The role of magnetic resonance imaging (MRI) in invasive lobular breast cancer based on mammographic density,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P20
281,Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P18
282,The value of head imaging after PET-CT staging in NSCLC,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P16
283,Imaging tumour response - challenges,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O14
284,Radiogenomics of glioblastoma: a window into its imaging and molecular variability,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P14
285,Patient experience of whole body diffusion weighted magnetic resonance imaging (WB-MRI) for staging myeloma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P13
286,An imaging review of extramedullary myeloma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P12
287,Value of PET-CT in plasma cell dyscrasias: a literature and pictorial review,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P11
288,Quantification of tumour heterogeneity and glucose metabolism on pre-chemoradiation PET/CT predicts survival in anal cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-S11
289,Small bowel masses,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O10
290,Comparison of standard staging protocol and WB-MRI for initial staging of rectal cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-S9
291,First case report of usefulness of 18F-FDG PET/CT in diagnosing typhlitis (an oncological emergency),http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P8
292,Value of pretreatment MRI determined parameters for predicting outcome after radio-frequency ablation of hepatocellular carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-S7
293,Factors in the success of the subcutaneous central venous port catheter in 626 colorectal carcinoma patients: long-term follow-up results according to the treatment groups,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P6
294,Imaging of IPMN of the pancreas: evaluation of malignant potential and resectability,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O6
295,Pre-treatment ADC histogram-analysis at whole body diffusion-weighted MRI predicts disease free survival in ovarian cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-S5
296,Hepatocellularcarcinoma: current imaging techniques,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P4
297,Spots and dots in the bones,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O4
298,Contrast enhancement for early cancer imaging by Gd-nanoparticles and active feedback MRI,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P2
299,Establishing proforma reporting in a busy DGH,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O2
300,Multiparametric magnetic resonance tomography and MRI/TRUS-fusion-biopsy for index lesion detection: correlation with radical prostatectomy specimen,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-S1
301,Value of DWI- ADC and FUSION T2-DWI in the management of oncological patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P52
302,Efficacy of PI-RADS in prebiopsy prostate-MRI at a urological cancer centre: a comparison with histology,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P41
303,Brain gliomas: reporting essentials and treatment response,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O39
304,Ovarian cancer: imaging in treatment selection and planning with FIGO update,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O38
305,Pearls and pitfalls in diagnosing prostate cancer using multiparametric MRI (mpMRI),http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P37
306,Fertility preservation in gynaecologic malignancy: imaging role in treatment planning,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P35
307,Imaging and cancer survivorship: challenges and changing concepts,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O33
308,Tractography of the prostatic neurovascular bundles: technique and interpretation,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P33
309,PET/MR imaging: current status and future direction,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O32
310,MR guided focused ultrasound,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O31
311,RECIST criteria: our experience in daily practice,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P31
312,Ablation for metastatic lung cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O29
313,Reducing error: benign abnormalities mimicking malignancy when reporting scans of patients with known malignancy,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P29
314,Orbital tumours,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O27
315,"Factors on patency periods of subcutaneous central venous port: long-term results of 1,408 patients",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P27
316,Salivary glands and lymph nodes,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O25
317,Effects of body composition as measured by CT on clinical outcomes in patients with oesophageal cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P25
318,Liver and pancreas,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O24
319,Lung and pleura,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O23
320,4th year medical student elective in multidisciplinary thoracic oncology,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P23
321,Imaging the Ancients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O21
322,"Chemotherapy induced cardiomyopathy: an overview, imaging features, and future prospective",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P21
323,Ultrasound with microbubbles,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O19
324,A pictorial series of interesting and unusual cases of breast malignancy encountered at triple assessment,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P19
325,MRI with hepatobiliary contrast,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O18
326,Microbubbles: from cancer detection to theranostics,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O17
327,Relating neurological symptoms to cerebral metastases at the time of initial staging scan,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P17
328,Theranostics: radionuclide imaging and therapy in neuroendocrine tumours,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O16
329,PET/CT imaging in prostate cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O15
330,Gadobenate dimeglumine (MultiHance) or gadoterat emeglumine (Dotarem) for brain tumour imaging? An intra-individual comparison,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P15
331,Lung cancer screening: 360 degree review,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O13
332,Small renal masses,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O12
333,CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-S12
334,Management of splenic “incidentalomas” found on ultrasound and computed tomography,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O11
335,Translating imaging biomarkers into clinical practice,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O9
336,Augmented reality: 3D image-guided surgery,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O8
337,Target versus non-target lesions in determining disease progression: analysis of 545 patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-S8
338,Characterisation of hepatobiliary lesions in an African referral hospital: initial MDCT dose challenges,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P7
339,Using structured reporting templates in staging pancreatic malignancies,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O7
340,Comparison of functional imaging in multiple myeloma patients: Indication for hybrid-imaging with PET/MRI?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-S6
341,Imaging of the pancreas: state of the art,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O5
342,Role of MRI in evaluation of small bowel disease,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P5
343,US perspective,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O3
344,Increase in lesion enhancement on gadoxetic acid enhanced MRI is associated with complete response to neoadjuvant chemotherapy in colorectal liver metastases,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P3
345,Advanced abdominal imaging with dual energy CT is feasible without increasing radiation dose,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-P1
346,Background/CASPAR study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-15-S1-O1
347,Approximation of head and neck cancer volumes in contrast enhanced CT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0051-3
348,FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0049-x
349,The presurgical T staging of non-small cell lung cancer: efficacy comparison of 64-MDCT and 3.0 T MRI,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0050-4
350,Primary hepatic neuroendocrine tumors: comparing CT and MRI features with pathology,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0046-0
351,Semi-automated segmentation of pre-operative low grade gliomas in magnetic resonance imaging,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0047-z
352,Diagnostic value of 18F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0048-y
353,Multi-modal imaging of tumor cellularity and Tryptophan metabolism in human Gliomas,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0045-1
354,STatistically Assigned Response Criteria in Solid Tumors (STARCIST),http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0042-4
355,Relevance of computerized tomography in the preoperative evaluation of patients with vulvar cancer: a prospective study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0044-2
356,Trans-arterial chemoembolization and external beam radiation therapy for treatment of hepatocellular carcinoma with a tumor thrombus in the inferior vena cava and right atrium,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0043-3
357,Diffusion-weighted MR neurography for the assessment of brachial plexopathy in oncological practice,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0041-5
358,Neuroblastoma and nephroblastoma: a radiological review,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0040-6
359,Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0039-z
360,Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0037-1
361,FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0038-0
362,"Computer-aided detection (CAD) system for breast MRI in assessment of local tumor extent, nodal status, and multifocality of invasive breast cancers: preliminary study",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-015-0036-2
363,Added value of advanced over conventional magnetic resonance imaging in grading gliomas and other primary brain tumors,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-014-0035-8
364,The use of FDG-PET in diffuse large B cell lymphoma (DLBCL): predicting outcome following first line therapy,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-014-0034-9
365,Morphological factors differentiating between early lung adenocarcinomas appearing as pure ground-glass nodules measuring ≤10 mm on thin-section computed tomography,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-014-0033-x
366,Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-014-0031-z
367,Usefulness of DWI in preoperative assessment of deep myometrial invasion in patients with endometrial carcinoma: a systematic review and meta-analysis,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-014-0032-y
368,Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-014-0030-0
369,Incidental findings in the oncology patient: ovaries,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O46
370,Incidental lesion in oncology patients: kidneys,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O44
371,Incidental findings in the oncology patient: liver,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O42
372,Batson’s plexus and retrograde venous spread of malignancy – a pictorial review,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P40
373,Optimising structural imaging of neuroendocrine tumours in the molecular imaging age,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P38
374,Imaging tumour response: beyond RECIST,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O36
375,Pictorial review of cardiac sarcomas and their mimickers,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P36
376,PET / MR as tool for ”precision medicine”,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O34
377,Alteration of MR-DWI/ADC before and 24h after induction of chemotherapy in patients with lung cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P34
378,Image directed lymph node sampling for lung cancer staging,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P32
379,Potential influence of automated volumetry on treatment response classifications in lung cancer lesions,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P30
380,Interest of reference region models to monitor cancer treatment using dynamic contrast enhanced studies,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P28
381,Relative time-intensity curve: a new method to differentiate benign and malignant lesions on breast MRI,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P26
382,Incremental diagnostic value of 18F-FDG PET/CT in the work up of adult limb and body wall sarcomas. A single centre experience,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P21
383,The impact of radiologists’ expertise on screen result decisions in CT lung cancer screening,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P19
384,Dual-energy CT for therapy monitoring: histogram analyses of iodine maps reveal typical pattern of enhancement,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P17
385,Evaluation of hepatic lesions in 30 proven cases of MEN-syndrome,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P15
386,Prospects and challenges of US and CEUS,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O13
387,Quantitative magnetic resonance imaging of microvascular changes in KHT sarcoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P13
388,Impact of three dimensional tomosynthesis on the detection and diagnosis of breast lesions,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P11
389,Staging the clinically negative neck in T1-T2 oral cancers: USgFNAC and sentinel node biopsy,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-S10
390,"Diagnostic accuracy of MRI in local staging of rectal cancer, and determining the surgical resection margin status; retrospective study. The experience in Oman",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P9
391,MRI for managing intermediate & low risk prostate cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O9
392,Three-dimensionally fused gadolinium-enhanced and diffusion-weighted images: value in determination of multi-centricity of breast carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-S8
393,Pictorial review of appearances post lung thermal ablation: what is normal?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P7
394,Imaging as a guide to tissue sampling,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O7
395,CT texture analysis of pulmonary lesions in patients suspected for lung cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-S6
396,Incidence of sarcoid-like reaction demonstrated on 18F-FDG PET-CT in head and neck cancer patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P5
397,Prevalence of osteoradionecrosis demonstrated in 18F-FDG PET-CT of post-high-dose-radiotherapy head and neck cancer patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P3
398,Challenges of cancer imaging in Africa,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O2
399,Therapy response assessment with quantitative PET: evaluation of a shortened acquisition protocol with dynamic PET/CT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-S1
400,How accurate is 18F-FDG-PET-CT in determining local cartilaginous/bony involvement by head & neck malignancy?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P1
401,Whole-body DWI in practice,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O47
402,Adrenal masses in oncology patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O45
403,Incidental findings in the oncology patient: pancreas and spleen,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O43
404,Pleura and lung,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O41
405,Role of dual phase MDCT in renal cancer – beyond the renal mass,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P41
406,Modern technology: lowering the radiation dose for lung cancer screening,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P39
407,Abdominal and pelvic complications of molecular targeted therapy,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O37
408,Imaging manifestations of unusual side effects of new anticancer medications,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P37
409,Response assessment in daily practice: RECIST and its modifications,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O35
410,Evaluation of hepatic flow changes in early stages after extended hepatectomy by contrast enhanced ultrasound,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P35
411,Beyond the image : sense and non-sense in imaging biomarkers,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O33
412,"Characterization of multiple myeloma osseous lesions and diffuse infiltration pattern by 18F-FDG-PET/CT, static MRI and diffusion-weighted MR Imaging (DWI-MRI): a comparative multimodality imaging study",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P33
413,Whole-body MRI and diffusion MRI,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O31
414,Imaging diagnostic standard in multiple endocrine neoplasia (MEN),http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P31
415,Role of molecular imaging in the detection of neuroendocrine tumour,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O29
416,Value of FDG PET/CT in the assessment of patients with colon cancer comparing to stand-alone CT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P29
417,CTPA for clinically suspected pulmonary emboli in oncology patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P27
418,Acute presentation of oncologic disease,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P25
419,Management of solid and sub-solid lung nodules,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O24
420,Utility of dual time point 18 FDG PET-CT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P24
421,FDG-PET in lymphoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O23
422,Use of textural analysis of tumour vascular heterogeneity as a biomarker of response to anti-angiogenic treatment in patients with nasopharyngeal carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P23
423,"Whole-body DWI in patients with lymphoma: imaging findings, pitfalls, and limitations",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O22
424,Fast venous return in inferior mesenteric vein: a new sign for rectosigmoid carcinoma on CT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P22
425,Radiological characteristics of screen-detected lung cancers: predictive for histological subtype?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P20
426,Metastasis: imaging shows the way,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O19
427,Ovarian cancer: imaging in treatment selection and planning with FIGO update,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O18
428,Diagnostic accuracy of staging of Wilms’ tumour in the era of multislice CT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P18
429,ICIS workshop on adnexal mass characterization,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O17
430,Pediatric tumours: liver tumours,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O16
431,What the radiologist needs to know about restaging of rectal carcinoma after chemoradiation therapy,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P16
432,Pediatric tumours: pseudotumour or a tumour?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O14
433,Dynamic 18FDG PET/CT and dynamic contrast enhanced MRI of locally advanced breast cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P14
434,The do’s and dont’s of liver CT and MR imaging,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O12
435,Prostate-MRI: experience of the observer and technical conditions influence the cancer detection rate,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P12
436,Diagnostic accuracy of Staging of Wilms’ Tumour in the era of multislice CT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-S12
437,Multiparametrical diffusion weighted imaging for the detection of anaplastic transformation of low-grade gliomas,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-S11
438,PSMA ligands for diagnosis and therapy of prostate cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O10
439,Chemotherapy response evaluation in metastatic non-small cell lung carcinoma (NSCLC) with 18F- FDG PET/CT and CT scan,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P10
440,Whole-body diffusion-weighted imaging for staging lymphoma: are apparent diffusion coefficient derived histogram parameters useful for lesion characterisation?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-S9
441,Patient outcome after pulmonary radiofrequency ablation: a prospective analysis of results from a single centre,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P8
442,"Whole-body diffusion-weighted MRI versus CT for detection, restaging and operability assessment of recurrent ovarian carcinoma",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-S7
443,What is the importance of solitary focal bony FDG-uptake on 18F-FDG PET-CT of known cancer patients?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P6
444,Robot-assisted navigation system for CT-guided percutaneous lung tumour procedures: our initial experience in Hong Kong,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-S5
445,Agreement of diameter- and volume-based pulmonary nodule management in CT lung cancer screening,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-S4
446,Prevalence of malignancy in patients with fever of unknown origin (FUO) demonstrated in 18F-FDG PET-CT – prospective multi-centre study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P4
447,Biliary tract neoplasms: detection and staging CT and Ultrasound,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O4
448,Localised prostate cancer treated with MRI-guided transurethral ultrasound ablation: phase I trial results,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-S3
449,Prostate-MRI: experience of the observer and technical conditions influence the cancer detection rate,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-S2
450,"Can we save our resources with half-body-18F-FDG-PET-CT rather than whole-body, in the management of head & neck cancers?",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-P2
451,"Highlights from the Abdominal Radiology Course, February 16–21, 2003, Cancun, Mexico",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0019
452,The pulmonary nodule: change of paradigm,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0018
453,The 5th scientific meeting of the CT-MRI Society of the Philippines,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0012
454,Contributions of multimodal imaging,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O40
455,Comprehensive breast MRI: an update,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O39
456,"Lung, CNS and musculo-skeletal targeted therapy-induced toxicity: imaging features",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O38
457,Hybrid imaging with PET/CT and PET/MR,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O32
458,Cancer imaging in the era of precision treatment: present and future,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O30
459,Imaging neuroendocrine tumours of the pancreas: role of CT and MRI,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O28
460,Noncommunicating cystic pancreatic lesions (i.e. serous and mucinous cystadenoma + rare lesions),http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O27
461,Characterization and management of cystic pancreatic neoplasms communicating lesions (IPMN),http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O26
462,Session: Evaluation of lung nodules: role of PET/CT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O25
463,Complications following locoregional therapy of renal cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O21
464,Locoregional therapy of renal cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O20
465,Neuroblastoma and nephroblastoma: an overview and comparison,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O15
466,Clinical management of patients with complicated multifocal disease,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O11
467,Screening & staging of colorectal cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O8
468,Staging of lung cancer CT and PET,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O6
469,MR imaging,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O5
470,Global challenges of cancer imaging: perspective from different parts of the world: Asia,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O3
471,Global challenges in oncologic imaging,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-S1-O1
472,Correlation between semiquantitative sonoelastography and immunohistochemistry in the evaluation of testicular focal lesions,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-014-0029-6
473,Chest-abdomen-pelvis CT for staging in cancer patients: dose effectiveness and image quality using automated attenuation-based tube potential selection,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/s40644-014-0028-7
474,Endoscopic ultrasound – fine needle aspiration of 2-deoxy-2-[18F] fluoro-D-glucose avid lymph nodes seen on positron emission tomography- computed tomography –what looks like cancer may not always be so,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-27
475,New targeted molecular therapies for cancer: radiological response in intrathoracic malignancies and cardiopulmonary toxicity: what the radiologist needs to know,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-26
476,The impact of 18 F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesions,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-25
477,A prospective investigation into the clinical impact of 4D-PET/CT in the characterisation of solitary pulmonary nodules,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-24
478,Mediastinal staging in non-small-cell lung carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-23
479,MR imaging features of intracranial primary CNS lymphoma in immune competent patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-22
480,Muscle metastases: comparison of features in different primary tumours,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-21
481,The role of diffusion and perfusion weighted imaging in the differential diagnosis of cerebral tumors: a review and future perspectives,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-20
482,Neoadjuvant intra-arterial chemotherapy in patients with primary lacrimal adenoid cystic carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-19
483,Imaging acute complications in cancer patients: what should be evaluated in the emergency setting?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-18
484,The evaluation of anti-angiogenic effects of Endostar on rabbit VX2 portal vein tumor thrombus using perfusion MSCT,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-17
485,Asymptomatic myocardial metastasis from cancers of upper aero-digestive tract detected on FDG PET/CT: a series of 4 cases,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-16
486,Prognostic factors in advanced pharyngeal and oral cavity cancer; significance of multimodality imaging in terms of 7th edition of TNM,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-15
487,Imaging of malignancies of the biliary tract- an update,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-14
488,The utility of 18 F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-13
489,RECIST measurements in cancer treatment: is there a role for physician assistants? - A pilot study,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-12
490,Investigation of the optimal b-value to detect breast tumors with diffusion weighted imaging by 1.5-T MRI,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-11
491,"Contrast-enhanced [18 F] fluorodeoxyglucose-positron emission tomography/computed tomography in clinical oncology: tumor-, site-, and question-based comparison with standard positron emission tomography/computed tomography",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-10
492,Dynamic multidetector computed tomography findings of hepatocellular carcinoma of hepatitis B virus-positive and -negative patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-9
493,The role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosis,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-8
494,Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-7
495,Clinical evaluation of semi-automatic landmark-based lesion tracking software for CT-scans,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-6
496,Imaging of pancreatic metastases from renal cell carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-5
497,Difficulty distinguishing benign notochordal cell tumor from chordoma further suggests a link between them,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-4
498,Prediction of pathologic prognostic factors in patients with lung adenocarcinomas: comparison of thin-section computed tomography and positron emission tomography/computed tomography,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-3
499,Prognostic value of volumetric metabolic parameters measured by [18F]Fluorodeoxyglucose-positron emission tomography/computed tomography in patients with small cell lung cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-2
500,Cancer imaging: Quo vadis?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1186/1470-7330-14-1
501,"Cancer Imaging 2002: principles, strategies, challenges",http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0018
502,Imaging liver metastases—size is important,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0040
503,Radiological assessment of neoadjuvant chemotherapy in breast cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0039
504,European Institute of Oncology project for lung cancer screening,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0038
505,The Radiology Diagnostic Oncology Group (RDOG) and the ovary,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0037
506,What’s up in abdominal radiology?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0036
507,Tumour oxygenation measurements using computed tomography and magnetic resonance imaging,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0035
508,Multislice CT in imaging the liver,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0016
509,The role of PET scanning in the staging of lung cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0034
510,CT colonography (‘virtual colonoscopy’): Is it ready for colorectal cancer screening?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0021
511,Evidence-based medicine: clinical utility of PET in oncology,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0033
512,The role of imaging in the management of primary pleural malignancies,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0020
513,What’s up in nuclear medicine?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0032
514,FDG-PET and colon cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0011
515,Indeterminate liver lesions in cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0010
516,MR imaging of pelvic lymph nodes,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0015
517,CT/MRI of nodal metastases in pelvic cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0015
518,Imaging findings of extraosseous multiple myeloma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0017
519,Lung metastases,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0010
520,Masson’s tumour of the kidney,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0016
521,MRI and PET of bone marrow in lymphoproliferative diseases,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0017
522,Spinal and meningeal metastatic disease,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0005
523,Work-up of the solitary pulmonary nodule,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0014
524,Prostate cancer: clinical questions and imaging answers,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0003
525,Indeterminate lesions in cancer (I): pelvic adnexal masses,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0013
526,Cystic pancreatic neoplasms,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0007
527,CT of splenic disease,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0012
528,Distinguishing benign from malignant adrenal masses,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0006
529,Indeterminate bone lesion: the diagnosis,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0011
530,Patterns of recurrence of bladder carcinoma following radical cystectomy,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0009
531,Polyarteritis nodosa mimicking a testis tumour: a case report and review of the literature,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0014
532,Radiological evaluation of oncologic treatment response: current update,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0013
533,Lymphoma: imaging in the evaluation of residual masses,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0008
534,Bone marrow imaging: follow-up after treatment in cancer patients,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0007
535,Aetiological factors and imaging program for severe radiation-induced extracranial carotid stenosis in nasopharyngeal carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0008
536,The surgeon’s view,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2001.010
537,Role of positron emission tomography in lung cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0006
538,Detecting and characterising small liver tumours,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0005
539,Nuclear medicine imaging in bone metastases,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0004
540,The role of PET scanning in the evaluation of lung carcinoma,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0003
541,Colon cancer screening,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2001.008
542,MR imaging of the prostate,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0002
543,Staging of upper GI malignancy,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0004
544,Proposals for lung cancer screening in the UK,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2001.006
545,Detection of peritoneal metastases,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2001.002
546,Staging of oesophageal cancer,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0001
547,Biliary malignancies: multi-slice CT or MRI?,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0002
548,CT demonstration of the spontaneous regression of a hypervascular lesion in cirrhotic liver,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2001.001
549,The early detection of liver metastases,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2002.0009
550,An unusual complication of prostatic bony metastases,http://cancerimagingjournal.biomedcentral.com/track/pdf/10.1102/1470-7330.2003.0001
